KAITLYN RIZZO: Open Payments
NPI 1659010338 · NORWALK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $208 |
| Novo Nordisk Inc | 1 | $124 |
| ABBVIE INC. | 4 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, QULIPTA, BREZTRI, REXULTI, GVOKE HYPOPEN, Fluad, VRAYLAR.
Industry payments across OH — which companies pay providers there.
